Jamie L. Miller, Pharm.D., BCPS, BCPPS, FPPAG

---

Publications & Presentations

71. Fox A, Villanueva R, Miller J L. Management of amiodarone extravasation with intradermal hyaluronidase. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 2017; 74 : 1545-1548

72. Fox A N, Villanueva R, Miller J L. Management of amiodarone extravasation with intradermal hyaluronidase. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 2017; 74 : 1545-1548

73. Johnson P N, Skrepnek G H, Golding C L, Owora A H, Thomas A N, Miller J L. Relationship between rate of fentanyl infusion and time to achieve sedation in nonobese and obese critically ill children. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 2017; 74 : 1174-1183

74. Jones A N, Miller J L, Neely S, Ibach B W, Hagemann T M, Golding C L, Lewis T V, Peek L A, Johnson P N. Prevalence of Unrounded Medication Doses and Associated Factors Among Hospitalized Pediatric Patients. The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG. 2017; 22 : 286-292

75. Dannelley J F, Martin E M, Chaaban H, Miller J L. Review of Metronidazole Dosing in Preterm Neonates. American journal of perinatology. 2017; 34 : 833-838

Grants

1. Evaluation of caffeine dosing regimens and the impact of developmental pharmacokinetics in neonates with apnea of prematurity. Misc Non-Federal. Start Date: 2020. End Date: 2021.

2. Characterization of fentanyl metabolic and renal elimination pathways in children less than two years of age. Misc Non-Federal. Start Date: 2018. End Date: 2020.

3. Development of a dose-exposure response relationship for detection of opioid tolerance in critically-ill children receiving fentanyl continuous infusions. Misc Non-Federal. Start Date: 2015. End Date: 2017.

4. Development of a dose-exposure response relationship for detection of opioid tolerance in critically-ill children receiving fentanyl continuous infusions. Misc Non-Federal. Start Date: 2015. End Date: 2017.

5. Comparison of amikacin pharmacokinetics in neonates pre- and post- a dosing protocol change. Misc Non-Federal. Start Date: 2014. End Date: 2015.

Awards and Honors

1. Oklahoma Residency Research Conference. Oklahoma Research Excellence Award (Mentor). Date: 2023.


2. Oklahoma Residency Research Conference. Oklahoma Research Excellence Award (Mentor). Date: 2023.


3. Pediatric Pharmacy Association. Christensen Memorial Young Investigator Award Nominee (Resident Mentor). Date: 2022.


4. Oklahoma Residency Research Conference. Oklahoma Research Excellence Award (Mentor). Date: 2019.


5. University of Oklahoma College of Pharmacy; Department of Clinical and Administrative Sciences. Best Paper Award. Date: 2018.

Education

1. Degree: PharmD. Southwestern Oklahoma State University. Date: 2006.


2. Degree: BS. Trevecca Nazarene University. Date: 2002.

Administrative Assignments

1. Role: Department Vice-Chair. Scope: Department. Date: 2021.

Read More